How we make your business thrive

1. Biomarker Discovery & Stratification

   We identify and validate biomarkers that define biologically distinct subtypes of depression and related disorders. Using multi-omics, imaging, and clinical data, we support patient stratification, target discovery, and trial enrichment.

2. Harmonized Assays & Data Integration

   Reliable results require consistent data. Our harmonized assay framework ensures that every biomarker — inflammatory, electrophysiological, or imaging-based — is produced under standardized, quality-controlled conditions. We integrate multi-source data into unified analytical pipelines for reproducible and regulatory-grade outputs.

3. Predictive Modeling & AI-Driven Analysis

   We build machine learning models that link biomarkers to treatment response, progression, and relapse risk. Our interpretable AI tools reveal the biological mechanisms driving outcomes, helping partners design smarter trials and personalized interventions.

4. Clinical Trial Enrichment & Companion Diagnostics

   By applying biomarker-based patient selection and response prediction, we support adaptive and enriched trial designs that reduce sample size and increase success rates. Our team collaborates with clinical partners to translate biomarker signatures into potential companion diagnostics.